Previous Page  13 / 16 Next Page
Information
Show Menu
Previous Page 13 / 16 Next Page
Page Background

Page 46

allied

academies

Case Reports in Surgery and Invasive Procedures | Volume 3

March 11-12, 2019 | London, UK

Biomarkers

Plastic and Cosmetic Surgery

International Conference on

International Conference on

Joint Event

&

Combination of oral lymecycline and (adapalene and benzyl peroxide) gel with salicylic peel in treat-

ment of nodulocystic acne in a female in fertile period: Case study

Manal Elsabae Gamil Sedrak

CosmeSurge, UAE

Background:

Clearance of nodulocystic acne lesions in a female

in fertile period where oral Isotretinoin cannot be given with

safety. Nodulocystic acne is a severe form of inflammatory

acne characterised by the presence of nodules and cysts that

are painful and often leave scarring. Because of this severe

type of acne can cause scarring, it’s best to start treating it as

quickly as possible. Oral antibiotics or isotretinoin is usually

prescribed; sometimes corticosteroid injections can be used for

immediate relief or to avoid scarring. One 24 years old newly

married female presented to the clinic with severe distressful

nodulocystic acne, oral Isotretinoin was totally unaccepted by

both the patient and her husband. Salicylic acid peel was done

after gentle evacuation of the lesions every 2 weeks interval,

together with Oral administration of lymecycline and topical

application of (adapalene Benzyl peroxide gel) evening time,

leaving a gap of 2 days interval before and after the peels.

Results:

Good improvement is seen after one month

with complete clearance of lesions within 3 months of

treatment. No scars are left behind, only post inflammatory

hyperpigmentations, with minimal macular scars that can be

handled by micro needling and laser combination.

Conclusion:

Safety and efficacy of combination treatment with

oral lymecycline and Adapalene perioxide gel with Salicylic

peels in patients in fertile period without taking the precautions

and risks oral Isotretinoin therapy.

e:

fady2001@hotmail.com

Notes: